Top

Published in:

01-11-2006 | Review Article

Molecular pathology of chondroid neoplasms: part 1, benign lesions

Authors: W. C. Bell, M. J. Klein, M. J. Pitt, G. P. Siegal

Published in: Skeletal Radiology | Issue 11/2006

Abstract

This two-part review presents an overview of the molecular findings associated with both benign and malignant chondroid neoplasms. This first part presents a brief review of methods in molecular pathology along with a review of the cytogenetic and molecular genetic findings in benign chondroid neoplasms. Clinical aspects of the various lesions are briefly discussed, and each tumor is illustrated with representative radiographic and pathologic images. Malignant chondroid neoplasms will be considered in the second part of this review.

Caspersson T, Zech L, Johansson C, Lindsten J, Hulten M. Fluorescent staining of heteropycnotic chromosome regions in human interphase nuclei. Exp Cell Res 1970;61(2):472–4.PubMedCrossRef

Harper ME, Saunders GF. Localization of single copy DNA sequences of G-banded human chromosomes by in situ hybridization. Chromosoma 1981;83(3):431–9.PubMedCrossRef

Pinkel D, Straume T, Gray JW. Cytogenetic analysis using quantitative, high-sensitivity, fluorescence hybridization. Proc Nat Acad Sci USA 1986;83(9):2934–8.PubMedCrossRef

Schrock E, du Manoir S, Veldman T, Schoell B, Wienberg J, Ferguson-Smith MA, et al. Multicolor spectral karyotyping of human chromosomes. Science 1996;273(5274):494–7.PubMed

Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F, et al. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 1992;258:818–21.PubMedCrossRef

Burnette WN. “Western blotting”: electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal Biochem 1981;112:195–203.PubMedCrossRef

Grizzle WE, Myers RB, Manne U, Srivastava S. Immunohistochemical evaluation of biomarkers in prostatic and colorectal neoplasia. In: Hanausek M, Walaszek Z (eds) Methods in molecular medicine-tumor marker protocols, Humana Press, Totowa, NJ, 1998;pp. 143–60.

Hutchen TW, Yip TT. New desorption strategies for the mass spectrometric analysis of macromolecules. Rapid Commun Mass Spectrom 1993;7:576–80.CrossRef

1 Fechner RE, Mills SE. Cartilaginous lesions. In: Atlas of tumor pathology, tumors of the bones and joints. Armed Forces Institute Pathol 1993;pp 79–128.

10.

Bridge JA, Persons DL, Neff JR, Bhatia P. Clonal karyotypic aberrations in enchondroma. Cancer Detec Prev 1992;16(4):215–19.PubMed

11.

Sawyer JR, Swanson CM, Lukacs JL, Nicholas RW, North PE, Thomas JR. Evidence of an association between 6q13–21 chromosome aberrations and locally aggressive behavior in patients with cartilage tumors. Cancer 1998;82(3):474–83.PubMedCrossRef

12.

Buddingh EP, Naumann S, Nelson M, Neffa JR, Birch N, Bridge JA. Cytogenetic findings in benign cartilaginous neoplasms. Cancer Gene Cytogene 2003;141(2):164–8.CrossRef

13.

Dal Cin P, Qi H, Sciot R, Van den Berghe H. Involvement of chromosomes 6 and 11 in a soft tissue chondroma. Cancer Gene Cytogene 1997;93(2):177–8.CrossRef

14.

Shadan FF, Mascarello JT, Newbury RO, Dennis T, Spallone P, Stock AD. Supernumerary ring chromosomes derived from the long arm of chromosome 12 as the primary cytogenetic anomaly in a rare soft tissue chondroma. Cancer Gene Cytogene 2000;118(2):144–7.CrossRef

15.

Dahlen A, Mertens F, Rydholm A, Brosjo O, Wejde J, Mandahl N, et al. Fusion, disruption, and expression of HMGA2 in bone and soft tissue chondromas. Mod Pathol 2003;16:1132–40.PubMedCrossRef

16.

Ozaki T, Wai D, Schafer KL, Lindner N, Bocker W, Winkelmann W, Dockhorn-Dworniczak B. Poremba C. Comparative genomic hybridization in cartilaginous tumors. Anticancer Res 2004;24:1721–25.PubMed

17.

Rozeman LB, Hameetman L, Cleton-Jansen AM, Taminiau AH, Hogendoorn PC, Bovee JV. Absence of IHH and retention of PTHrP signalling in enchondromas and central chondrosarcomas. J Pathol 2005;205(4):476–82.PubMedCrossRef

18.

Ozisik YY, Meloni AM, Spanier SS, Bush CH, Kingsley KL, Sandberg AA. Deletion 1p in a low-grade chondrosarcoma in a patient with Ollier disease. Cancer Gene Cytogene 1998;105:128–33.CrossRef

19.

Amling M, Posl M, Hentz MW, Priemel M, Delling G. PTHrP an Bcl–2: essential regulatory molecules in chondrocyte differentiation and chondrogenic tumors. Verh Dtsch 1998;82:160–9.

20.

Rozeman LB, Sangiorgi L, Briaire-de Bruijn IH, Mainil-Varlet P, Bertoni F, Cleton-Jansen AM, et al. Enchondromatosis (Ollier disease, Maffucci syndrome) is not caused by the PTHR1 mutation p.R150C. Human Mutat 2004;24(6):466–73.CrossRef

21.

Hopyan S, Gokgoz N, Poon R, Gensure RC, Yu C, Cole WG, et al. A mutant PTH/PTHrP type I receptor in enchondromatosis. Nat Genet 2002;30(3):306–10.PubMedCrossRef

22.

Kusuzaki K, Murata H, Takeshita H, Hirata M, Hashiguchi S, Tsuji Y, et al. Mod Pathol 1999;12(9):863–72.PubMed

23.

Bridge JA, Nelson M, Orndal C, Bhatia P, Neff JR. Clonal karyotypic abnormalities of the hereditary multiple exostoses chromosomal loci 8q24.1 (EXT1) and 11p11–12 (EXT2) in patients with sporadic and hereditary osteochondroma. Cancer 1998;82:1657–63.PubMedCrossRef

24.

Wuyts W, Van Hul W. Molecular basis of multiple exostoses: mutations in the EXT1 and EXT2 genes. Human Mutat 2000;15:220–7.CrossRef

25.

Bernard MA, Hall CE, Hogue DA, Cole WG, Scott A, et al. Diminished levels of the putative tumor suppressor proteins EXT1 and EXT2 in exostoses chondrocytes. Cell Motil Cytoskelet 2001;48:149–62.CrossRef

26.

Wuyts W, Van Hul W, Wauters J, Nemtsova M, et al. Postitional cloning of a gene involved in hereditary multiple exostoses. Hum Mol Gene 1996;5:1547–57.CrossRef

27.

Ahn J, Ludecke H, Lindow S, Horton WA, Lee B, Wagner MJ, et al. Cloning of the putative tumour suppressor gene for hereditary multiple exostoses (EXT1). Nat Gene 1995;11:137–43.CrossRef

28.

McCormick C, Duncan G, Goutsos T, Tufaro F. The putative tumor suppressors EXT1 and EXT2 form a stable complex that accumulates in the Golgi apparatus and catalyzes the synthesis of heparin sulfate. Proc Nat Acad Sci USA 2000;97:668–73.PubMedCrossRef

29.

Duncan G, McCormick C, Tufaro F. The link between heparin sulfate and hereditary bone disease: finding a function for the EXT family of putative tumor suppressor proteins. J Clin Invest 2001;108:511–6.PubMedCrossRef

30.

Lin X, Wei G, Shi Z, Dryer L, Esko JD, Wells DE, et al. Disruption of gastrulation and heparan sulfate biosynthesis in EXT1-deficient mice. Dev Biol 2000;224:299–311.PubMedCrossRef

31.

Sjogren H, Orndal C, Tingby O, Meis-Kindblom JM, Kindblom LG, Stenman G. Cytogenetic and spectral karyotype analyses of benign and malignant cartilage tumours. Int J Oncol 2004;24:1385–91.PubMed

32.

Halbert AR, Harrison WR, Hicks MJ, Davino N, Cooley LD. Cytogenetic analysis of a scapular chondromyxoid fibroma. Cancer Gene Cytogene 1998;104:52–6.CrossRef

33.

Granter SR, Renshaw AA, Kozadewich HP, Fletcher JA. The pericentromeric inversion, inv (6)(p25q13), is a novel diagnostic marker in chondromyxoid fibroma. Mod Pathol 1998;11:1071–74.PubMed

34.

Safar A, Nelson M, Neff JR, Maale GE, Bayani J, Squire J, et al. Recurrent anomalies of 6q25 in chondromyxoid fibroma. Human Pathol 2000;31:306–11.CrossRef

35.

Romeo S, Bovee JV, Grogan SP, Taminiau AH, Eilers PH, Cleton-Jansen AM, et al. Chondromyxoid fibroma resembles in vitro chondrogenesis, but differs in expression of signalling molecules. J Pathol 2005;206:135–42.PubMedCrossRef

36.

Swarts SJ, Neff JR, Johansson SL, Nelson M, Bridge JA. Significance of abnormalities of chromosomes 5 and 8 in chondroblastoma. Clin Orthop Relat Res 1998;349:189–93.PubMedCrossRef

37.

van Zelderen-Bhola SL, Bovee JV, Wessels HW, Mollevanger P, Nijhuis JV, van Eendenburg JD, et al. Ring chromosome 4 as the sole cytogenetic anomaly in a chondroblastoma: a case report and review of the literature. Cancer Gene Cytogene 1998;105:109–12.CrossRef

38.

Aigner T, Loos S, Inwards C, Perris R, Perissinotto D, Unni KK, et al. Chondroblastoma is an osteoid-forming, but not cartilage-forming neoplasm. J Pathol 1999;189:463–9.PubMedCrossRef

39.

Nora FE, Dahlin DC, Beabout JW. Bizarre parosteal osteochondromatous proliferations of the hands and feet. Am J Surg Pathol 1983;51:245–50.CrossRef

40.

Nilsson M, Domanski HA, Mertens F, Mandahl N. Molecular cytogenetic characterization of recurrent translocation breakpoints in bizarre parosteal osteochondromatous proliferation (Nora’s lesion). Hum Pathol 2004;35:1063–9.PubMedCrossRef

41.

Zambrano E, Nose V, Perez-Atayde AR, Gebhardt M, Hresko MT, Kleinman P, et al. Distinct chromosomal rearrangements in subungual (Dupuytren) exostosis and bizarre parosteal osteochondromatous proliferation (Nora’s lesion). Am J Surg Pathol 2004;28:1033–9.PubMed

Title: Molecular pathology of chondroid neoplasms: part 1, benign lesions
Authors: W. C. Bell
M. J. Klein
M. J. Pitt
G. P. Siegal
Publication date: 01-11-2006
Publisher: Springer-Verlag
Published in: Skeletal Radiology / Issue 11/2006
Print ISSN: 0364-2348
Electronic ISSN: 1432-2161
DOI: https://doi.org/10.1007/s00256-006-0191-4

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Molecular pathology of chondroid neoplasms: part 1, benign lesions

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 11/2006

Pseudotumoral appearance of a ruptured epidermal cyst in the foot

Giant epidermal inclusion cyst of buttock

Progressive massive osteolysis secondary to benign squamous epithelial colonisation in chronic osteomyelitis

Paleoradiology: imaging disease in mummies and ancient skeletons

Pattern of osteophytes and enthesophytes in the proximal ulna: an anatomic, paleopathologic, and radiologic study

Incidence and MR imaging features of fractures of the anterior process of calcaneus in a consecutive patient population with ankle and foot symptoms